Latest Quarterly Report
Filed: 2026-02-13
Key Insights
- The company reported a significant decline in revenue and profitability over the past year, indicating potential operational challenges.
- The company has entered into a securities purchase agreement to raise additional capital, which could help fund its ongoing operations and development efforts.
- The company's acquisition of two subsidiaries, Beyond Cancer Ltd and NeuroNos Ltd, suggests a shift in its strategic focus towards new business areas.